Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2022 - 2026)

Kiniksa Pharmaceuticals International has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.95 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 16.37% year-over-year to 0.95; the trailing twelve-month figure through Mar 2026 stood at 0.95 (up 16.37% YoY), and the FY2025 full-year result was 1.01, up 31.83% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.95, up from 0.92 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.95 in Q1 2026, with the low at 0.02 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.54 across 5 years, with a median of 0.58 in 2024.
• The largest YoY upside for Asset Utilization Ratio was 2362.26% in 2023 against a maximum downside of 84.9% in 2023.
• Kiniksa Pharmaceuticals International's Asset Utilization Ratio stood at 0.02 in 2022, then soared by 2362.26% to 0.54 in 2023, then jumped by 39.17% to 0.75 in 2024, then rose by 23.2% to 0.92 in 2025, then rose by 3.38% to 0.95 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.95 (Q1 2026), 0.92 (Q4 2025), and 0.87 (Q3 2025), per Business Quant data.